This month's speaker is Dr. Jordan Watson, Nemours Children's Hospital, Delaware, Department of Dermatology. She will discuss evaluation and management of mild to moderate acne often seen in the primary care office.

Objectives

  • Evaluate and treat patients with mild to moderate acne in the primary care setting.
  • Discuss common patient concerns regarding topical acne medications.

Practice Change

  • Utilize both topical and oral antibiotics for acne management in keeping with guidelines for antimicrobial stewardship

Click on Take Course at the bottom of the page to access the Microsoft Teams link for today's session.

No one in control of content for this educational activity has relevant financial relationship(s) to disclose with **ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Session date: 
05/09/2024 - 12:15pm to 1:00pm EDT
Location: 
Virtual Via Microsoft Teams
  • 0.75 MOC ABS – Surgery
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
  • 0.75 AMA PRA Category 1 Credit

    The Nemours Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    The Nemours Foundation designates this activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 0.75 Continuing Education
    This activity is designated for 0.75 continuing education credits.

Please login or register to take this course.
Faculty List: 
Speaker(s)

Jordan Watson, MD, FAAP

has no relevant financial relationships to disclose at this time.